To elucidate the impact of FOXC1 on stem-like properties in ESCC, we employed siRNA to knock down FOXC1 in ECA-109 and KYSE-150 cell lines, subsequently conducting RNA sequencing to analyze differentially expressed genes. The gene discussed is FOXC1; the disease is esophageal squamous cell carcinoma.